INTEGRATED BIOPHARMA INC Annual Depreciation in USD from 2012 to 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Integrated Biopharma Inc quarterly/annual Depreciation history and growth rate from 2012 to 2024.
Integrated Biopharma Inc Depreciation for the quarter ending September 30, 2024 was $88K, a 14.3% increase year-over-year.
Integrated Biopharma Inc Depreciation for the twelve months ending September 30, 2024 was $330K, a 2.94% decline year-over-year.
Integrated Biopharma Inc annual Depreciation for 2024 was $319K, a 9.12% decline from 2023.
Integrated Biopharma Inc annual Depreciation for 2023 was $351K, a 4.46% increase from 2022.
Integrated Biopharma Inc annual Depreciation for 2022 was $336K, a 0.3% decline from 2021.

Depreciation, Trailing 12 Months (USD)

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	$319K	-$32K	-9.12%	Jul 1, 2023	Jun 30, 2024	10-K	2024-09-20
2023	$351K	+$15K	+4.46%	Jul 1, 2022	Jun 30, 2023	10-K	2024-09-20
2022	$336K	-$1K	-0.3%	Jul 1, 2021	Jun 30, 2022	10-K	2023-09-15
2021	$337K	+$25K	+8.01%	Jul 1, 2020	Jun 30, 2021	10-K	2022-09-13
2020	$312K	+$24K	+8.33%	Jul 1, 2019	Jun 30, 2020	10-K	2021-09-02
2019	$288K	+$49K	+20.5%	Jul 1, 2018	Jun 30, 2019	10-K	2020-09-23
2018	$239K	-$53K	-18.2%	Jul 1, 2017	Jun 30, 2018	10-K	2019-08-29
2017	$292K	+$46K	+18.7%	Jul 1, 2016	Jun 30, 2017	10-K	2018-09-12
2016	$246K	-$22K	-8.21%	Jul 1, 2015	Jun 30, 2016	10-K	2017-09-01
2015	$268K	+$15K	+5.93%	Jul 1, 2014	Jun 30, 2015	10-K	2016-09-02
2014	$253K	-$36K	-12.5%	Jul 1, 2013	Jun 30, 2014	10-K	2015-09-04
2013	$289K	-$70K	-19.5%	Jul 1, 2012	Jun 30, 2013	10-K	2014-09-08
2012	$359K			Jul 1, 2011	Jun 30, 2012	10-K	2013-09-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.